In just one week after receiving their final dose of Melanotan 2, measurements in the subjects confirmed a quantifiable increase in their skin pigmentation
CGMs help patients identify food triggers by showing exactly which meals cause glucose spikes, so patients know exactly what to change instead of guessing
It was originally developed for the management of type 2 diabetes and later received FDA approval for chronic weight management in adults with obesity or those who are overweight with at least one weight-related health condition
1 Beyond diabetes and obesity Cardiovascular disease In March 2024, the US Food and Drug Administration (FDA) approved Wegovy (semaglutide) for adults with cardiovascular disease (CVD) and either obesity and overweight to reduce the risk of cardiovascular death, heart attack, and stroke
However, further research and clinical trials are necessary to determine its suitability for human use [7]
This age-related decline correlates with decreasing tissue regenerative capacity